Partner Therapeutics to focus on commercial and late-stage cancer therapies.

BOSTON, Jan. 25, 2018-PRNewswire

Biotech and pharmaceutical executives Robert Mulroy and Dr. Debasish Roychowdhury announced today the launch of Partner Therapeutics, or PTx, an oncology company that is focused on the development and commercialization of approved and late-stage therapies. The Boston-area company is committed to supporting patient care with medicines that improve cancer treatment outcomes and reduce the total cost of care.

Mr. Mulroy and Dr. Roychowdhury are biopharma veterans who combined have ...